Close

Oasmia Pharma (OASM) Enters New Shares Private Placement

Go back to Oasmia Pharma (OASM) Enters New Shares Private Placement

Oasmia Pharma (OASM) to Acquire KB9520 Project from Karo Pharma

October 24, 2016 7:13 AM EDT

Oasmia (Nasdaq: OASM) and Karo Pharma have entered into an agreement concerning Karo Pharma's cancer project KB9520, which has shown promising results in pre-clinical models for a number of different types of cancer.

Oasmia acquires the project and strengthens its oncology project portfolio. Karo Pharma receives 3,080,000 newly issued shares as a down payment corresponding to a value of MSEK 25.... More

Oasmia Pharma (OASM) Says It's in Discussions on Acquisition of Novel Cancer Project

October 21, 2016 4:22 PM EDT

The pharmaceutical company Oasmia Pharmaceutical AB (NASDAQ: OASM) announce today that the company is in discussions concerning acquisition of a novel cancer project.

More information will be released on Monday at the latest.

... More